What is Acomplia Rimonabant? Sanofi-Aventis, a French drug maker developed Rimonabant in an effectual weight loss medication, Acomplia. Rimonabant  constitutes the main active ingredient of Acomplia, thereby working as an effective appetite suppressant. Use of Acomplia Rimonabant diet pill helps in weight loss by suppressing  your normal appetite. This implies, that you would eat in small portions and in turn is beneficial in shedding of those extra pounds.
 
Effectual weight loss results is not the only benefit sourced by Acomplia Rimonabant. clinical trials of 2 years of, have identified other benefits of Acomplia Rimonabant too. Usage of Acomplia weight loss medication is also beneficial in smoking cessation, restitution of cardio- metabolic risk factors, and even condenses the probability of weight regain. 

Individuals below the age group of 18years, women planning pregnancy, pregnant women, nursing mothers, diabetics, and heart patients should refrain from usage of Acomplia Rimonabant. Acomplia Rimonabant is available in the strength of 10 mg and 20 mg tablets, which should be followed in strict adherence to doctors’ prescription. It is advisable to seek medical consultation before initiating Acomplia treatment.

Weight loss prescription Acomplia (Rimonabant) has been made available for sale in the UK, Sweden, France, Germany, Holland, Ireland, Austria along with other European countries. Amongst other soon-to-be countries which are most probable to benefit from Acomplia sale in the coming future are Spain, Italy, and Mexico. Although its US launch is much awaited but it has been stalled due to delay in the FDA approval for some unveiled reasons.